Validation of an ex vivo human cervical tissue model for the local delivery of nucleic acid drugs
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: AMANN, Annette (Across Barriers GmbH, SaarbrÜcken, Germany)
- Co-author(s): Bock, Udo (Across Barriers GmbH, SAARBRÜCKEN, Germany)
Haltner-Ukomadu, Eleonore (Across Barriers GmbH, SAARBRÜCKEN, Germany)
The human cervix is the point of origin of cervical cancer, the second most common female tumor entity worldwide. The necessary cause of cervical cancer is the infection of the cervix with high risk types of human papilloma virus (HPV). To address a local therapy with nucleic acid drugs it is important to understand the barrier properties of the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.